Pune, Maharashtra -- (SBWire) -- 02/19/2019 --Pharmaceutical companies are increasingly collaborating with medical institutes and research centers in order to ramp up R&D pipelines of peptide drugs. This is expected to influence the growth of the global peptide based gastrointestinal disorders therapeutics market over the next couple of years. Rising prevalence of metabolic diseases and gastrointestinal disorders pertaining to the digestive system is prompting medical practitioners to utilize new therapeutics including peptides. In the near future, application of peptides is also expected to increase in other therapeutic areas as well. Moreover, technological advancement in peptide synthesis which include hybrid combination of liquid and solid synthesis and high-throughput approaches is expected to play a crucial role in development of more effective peptide based therapeutic drugs for treating gastrointestinal disorders. Such developments in the peptide therapeutics is also giving new hope to patients seeking affordable and effect therapeutic treatments. In addition, manufacturers are actively focusing on improving peptide properties, such as half-life and stability to address the various unmet medical needs. According to the latest report published by Fact.MR, the global peptide based gastrointestinal disorders therapeutics market is set to reflect a double-digit CAGR between 2017 and 2022, to surpass a valuation of US$ 600 Mn.
Request Sample Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=190
North America to Lead the Global Peptide Based Gastrointestinal Disorders Therapeutics Market
In terms of revenue, North America is expected to hold the dominant share of the global peptide based gastrointestinal disorders therapeutics market in 2017 and beyond. Factors such growing patient awareness and rapid adoption of peptide based therapeutics for treating various diseases are expected to support the growth of the market in the region. During the forecast period, the market in the region is projected to surge at a robust CAGR of 13.9%.
On the basis of drugs, the linaclotide segment is expected to retain its dominant position over 2022. Currently, the segment accounts for more than two-third share of the market in terms of revenue. Towards the end of the forecast period, the linaclotide segment is estimated to reach a market valuation in excess of US$ 466 Mn.
Competition Tracking
Shire plc, Ironwood Pharmaceuticals, Inc., Astellas Pharma Inc., Allergan plc, Accredo Health Group, Inc., are the key market players profiled in the Fact.MR's report. A majority of these companies are channelizing investment in further expansion of their product portfolio. This, in turn, is anticipated to result in introduction of more efficacious peptide based therapeutic drugs for curing gastrointestinal ailments.
Request/View Toc@ https://www.factmr.com/connectus/sample?flag=T&rep_id=190
Detailed TOC of Global Peptide Based Gastrointestinal Disorders Therapeutics Market by Manufacturers, Regions, Type and Application, Forecast to 2022
1. Global Peptide Based Gastrointestinal Disorders Therapeutics Market - Executive Summary
2. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Overview
2.1. Introduction
2.1.1. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Taxonomy
2.1.2. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Definition
2.2. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size (US$ Mn) and Forecast, 2012-2022
2.2.1. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Y-o-Y Growth
2.3. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Dynamics
2.4. Regulations
2.5. Supply Chain
2.6. Cost Structure
2.7. Average Pricing Analysis
2.8. Epidemiology
2.9. Key Participants Market Presence (Intensity Map) By Region
Speak To Research Analyst for Detailed Insights @ https://www.factmr.com/connectus/sample?flag=AE&rep_id=190
3. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Analysis and Forecast By Drug
3.1. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast By Drug, 2012-2022
3.1.1. Teduglutide Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast, 2012-2022
3.1.1.1. Revenue (US$ Mn) Comparison, By Region
3.1.1.2. Market Share Comparison, By Region
3.1.1.3. Y-o-Y growth Comparison, By Region
3.1.2. Linaclotide Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast, 2012-2022
3.1.2.1. Revenue (US$ Mn) Comparison, By Region
3.1.2.2. Market Share Comparison, By Region
3.1.2.3. Y-o-Y growth Comparison, By Region
4. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Analysis and Forecast By Distribution Channel
4.1. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast By Distribution Channel, 2012-2022
4.1.1. Hospital Pharmacies Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast, 2012-2022
4.1.1.1. Revenue (US$ Mn) Comparison, By Region
4.1.1.2. Market Share Comparison, By Region
4.1.1.3. Y-o-Y growth Comparison, By Region
4.1.2. Retail Pharmacies Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast, 2012-2022
4.1.2.1. Revenue (US$ Mn) Comparison, By Region
4.1.2.2. Market Share Comparison, By Region
4.1.2.3. Y-o-Y growth Comparison, By Region
4.1.3. Online Pharmacies Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast, 2012-2022
4.1.3.1. Revenue (US$ Mn) Comparison, By Region
4.1.3.2. Market Share Comparison, By Region
4.1.3.3. Y-o-Y growth Comparison, By Region
Access This Report @ https://www.factmr.com/checkout/190/S
5. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Analysis and Forecast By Region
5.1. Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast, 2012-2022
5.1.1. North America Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast, 2012-2022
5.1.1.1. Revenue (US$ Mn) Comparison, By Drug
5.1.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel
5.1.2. Latin America Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast, 2012-2022
5.1.2.1. Revenue (US$ Mn) Comparison, By Drug
5.1.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel
5.1.3. Europe Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast, 2012-2022
5.1.3.1. Revenue (US$ Mn) Comparison, By Drug
5.1.3.2. Revenue (US$ Mn) Comparison, By Distribution Channel
5.1.4. Japan Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast, 2012-2022
5.1.4.1. Revenue (US$ Mn) Comparison, By Drug
5.1.4.2. Revenue (US$ Mn) Comparison, By Distribution Channel
5.1.5. APEJ Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast, 2012-2022
5.1.5.1. Revenue (US$ Mn) Comparison, By Drug
5.1.5.2. Revenue (US$ Mn) Comparison, By Distribution Channel
5.1.6. MEA Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast, 2012-2022
5.1.6.1. Revenue (US$ Mn) Comparison, By Drug
5.1.6.2. Revenue (US$ Mn) Comparison, By Distribution Channel
6. North America Peptide Based Gastrointestinal Disorders Therapeutics Market Analysis and Forecast, By Country, 2012-2022
6.1. US Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast, 2012-2022
6.1.1. Revenue (US$ Mn) Comparison, By Drug
6.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel
6.2. Canada Peptide Based Gastrointestinal Disorders Therapeutics Market Size and Forecast, 2012-2022
6.2.1. Revenue (US$ Mn) Comparison, By Drug
6.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel
And Continue...
List of Figures, Tables and Charts Available in Global Peptide Based Gastrointestinal Disorders Therapeutics Market 2017 by Manufacturers, Regions, Type and Application, Forecast to 2022
TABLE 1 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), 2012-2016
TABLE 2 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), 2017-2022
TABLE 3 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn) and Y-o-Y, 2015-2022
TABLE 4 Global Teduglutide Segment Value (US$ Mn), By Region 2012-2016
TABLE 5 Global Teduglutide Segment Value (US$ Mn), By Region 2017-2022
TABLE 6 Global Teduglutide Segment Market Share, By Region 2012-2016
TABLE 7 Global Teduglutide Segment Market Share, By Region 2017-2022
TABLE 8 Global Teduglutide Segment Y-o-Y, By Region 2015-2022
TABLE 9 Global Linaclotide Segment Value (US$ Mn), By Region 2012-2016
TABLE 10 Global Linaclotide Segment Value (US$ Mn), By Region 2017-2022
TABLE 11 Global Linaclotide Segment Market Share, By Region 2012-2016
TABLE 12 Global Linaclotide Segment Market Share, By Region 2017-2022
TABLE 13 Global Linaclotide Segment Y-o-Y, By Region 2015-2022
TABLE 14 Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2012-2016
And Continue...
FIG. 1 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn), 2012-2016
FIG. 2 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn) Forecast, 2017-2022
FIG. 3 Global Peptide Based Gastrointestinal Disorders Therapeutics Market Value (US$ Mn) and Y-o-Y, 2015-2022
FIG. 4 Global Teduglutide Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 5 Global Teduglutide Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 6 Global Teduglutide Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 7 Global Linaclotide Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 8 Global Linaclotide Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 9 Global Linaclotide Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 10 Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 11 Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 12 Global Hospital Pharmacies Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 13 Global Retail Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 14 Global Retail Pharmacies Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 15 Global Retail Pharmacies Segment Y-o-Y Growth Rate, By Region, 2015-2022
And Continue....
About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
Rohit Bhisey
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Read Industry News at - https://theswisstimes.com
Peptide Based Gastrointestinal Disorders Therapeutics Revenue, Opportunity, Forecast and Value Chain 2018-2020
Fact.MR has announced the addition of the “ Peptide Based Gastrointestinal Disorders Therapeutics Market Forecast, Trend Analysis & Competition Tracking - Global Market insights 2018 to 2028"report to their offering.